TNXP Tonix Pharmaceuticals Holding Corp

USD 0.33 -0.01 -2.41791
Icon

Tonix Pharmaceuticals Holding Corp (TNXP) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.3269

-0.01 (-2.42)%

USD 0.02B

1.57M

N/A

USD 1.60 (+389.45%)

Icon

TNXP

Tonix Pharmaceuticals Holding Corp (USD)
COMMON STOCK | NSD
USD 0.33
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.02B

USD 1.60 (+389.45%)

USD 0.33

Tonix Pharmaceuticals Holding Corp (TNXP) Stock Forecast

N/A

Based on the Tonix Pharmaceuticals Holding Corp stock forecast from 0 analysts, the average analyst target price for Tonix Pharmaceuticals Holding Corp is not available over the next 12 months. Tonix Pharmaceuticals Holding Corp’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Tonix Pharmaceuticals Holding Corp is Bearish, which is based on 2 positive signals and 5 negative signals. At the last closing, Tonix Pharmaceuticals Holding Corp’s stock price was USD 0.3269. Tonix Pharmaceuticals Holding Corp’s stock price has changed by -8.71% over the past week, -11.17% over the past month and -90.66% over the last year.

No recent analyst target price found for Tonix Pharmaceuticals Holding Corp
No recent average analyst rating found for Tonix Pharmaceuticals Holding Corp

Company Overview Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals Holding Corp., a biopharmaceutical company, focuses on developing, discovering, commercializing, and licensing therapeutics to treat and prevent human disease and alleviate suffering. It markets Zembrace SymTouch and Tosymra for the treatment of acute migrai...Read More

https://www.tonixpharma.com

26 Main Street, Chatham, NJ, United States, 07928

117

December

USD

USA

Adjusted Closing Price for Tonix Pharmaceuticals Holding Corp (TNXP)

Loading...

Unadjusted Closing Price for Tonix Pharmaceuticals Holding Corp (TNXP)

Loading...

Share Trading Volume for Tonix Pharmaceuticals Holding Corp Shares

Loading...

Compare Performance of Tonix Pharmaceuticals Holding Corp Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for TNXP

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Tonix Pharmaceuticals Holding Corp (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc -1.14 (-0.27%) USD107.38B 29.93 21.06

ETFs Containing TNXP

Symbol Name TNXP's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Tonix Pharmaceuticals Holding Corp (TNXP) Stock

Stock Target Advisor's fundamental analysis for Tonix Pharmaceuticals Holding Corp's stock is Bearish.

Unfortunately we do not have enough data on TNXP's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on TNXP's stock to indicate what its average analyst target is.

TNXP stock's Price/Earning ratio is 0.14. Our analysis grades TNXP stock's Price / Earning ratio at B. This means that TNXP stock's Price/Earning ratio is above 15% of the stocks in the Biotechnology sector in the NSD exchange. Based on this TNXP may be undervalued for its sector.

The last closing price of TNXP's stock was USD 0.33.

The most recent market capitalization for TNXP is USD 0.02B.

Unfortunately we do not have enough analyst data on TNXP's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Tonix Pharmaceuticals Holding Corp's stock.

As per our most recent records Tonix Pharmaceuticals Holding Corp has 117 Employees.

Tonix Pharmaceuticals Holding Corp's registered address is 26 Main Street, Chatham, NJ, United States, 07928. You can get more information about it from Tonix Pharmaceuticals Holding Corp's website at https://www.tonixpharma.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...